Develop tools and techniques to assess environmental risks posed by emerging and innovative medicines e.g. nano-based medicines and biologic-based therapies > Address the global environmental risks posed by PIE, especially in Emerging Markets where there are different standards of water management and novel exposure scenarios > Understand the relationship between the environmental dimension of AMR and resistance in the clinic.